| |
| |
|
| Insider
Information: |
Stern Stanley |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
190,257 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$305,137 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
190,257 |
|
|
| Total
Value |
$305,137 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -27.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ormat Technologies Inc |
ORA |
Director |
2024-03-28 |
4,835 |
2018-11-07 |
0 |
Premium* |
|
|
Foamix Pharmaceuticals Ltd |
FOMX |
Director |
2020-03-09 |
0 |
2019-05-16 |
0 |
Premium* |
|
|
Roth Ch Acquisition Iv Co. |
ROCGU |
Director |
2023-08-11 |
185,422 |
2023-05-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ORA |
Ormat Technologies Inc |
Director |
• • – |
2024-03-28 |
4 |
S |
$66.95 |
$122,184 |
D/D |
(1,825) |
4,835 |
0 |
% |
|
| ORA |
Ormat Technologies Inc |
Director |
• • – |
2023-11-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
623 |
6,660 |
0 |
- |
|
| ROCGU |
Roth Ch Acquisition Iv Co... |
Director |
– • – |
2023-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
16,304 |
185,422 |
0 |
- |
|
| ROCGU |
Roth Ch Acquisition Iv Co... |
Director |
– • – |
2023-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
169,118 |
169,118 |
0 |
- |
|
| ORA |
Ormat Technologies Inc |
Director |
• • – |
2023-05-19 |
4 |
S |
$84.42 |
$161,968 |
D/D |
(1,918) |
6,037 |
0 |
% |
|
| ORA |
Ormat Technologies Inc |
Director |
• • – |
2023-05-19 |
4 |
D |
$84.19 |
$86,214 |
D/D |
(1,024) |
7,955 |
0 |
- |
|
| ORA |
Ormat Technologies Inc |
Director |
• • – |
2023-05-19 |
4 |
OE |
$63.35 |
$86,219 |
D/D |
1,361 |
8,979 |
0 |
- |
|
| ORA |
Ormat Technologies Inc |
Director |
• • – |
2022-11-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,581 |
7,618 |
0 |
- |
|
| ORA |
Ormat Technologies Inc |
Director |
• • – |
2022-08-16 |
4 |
S |
$96.85 |
$726,375 |
D/D |
(7,500) |
6,037 |
0 |
% |
|
| ORA |
Ormat Technologies Inc |
Director |
• • – |
2022-08-16 |
4 |
OE |
$47.46 |
$355,950 |
D/D |
7,500 |
13,537 |
0 |
- |
|
| ORA |
Ormat Technologies Inc |
Director |
• • – |
2022-03-31 |
4 |
S |
$80.85 |
$606,375 |
D/D |
(7,500) |
6,037 |
0 |
% |
|
| ORA |
Ormat Technologies Inc |
Director |
• • – |
2022-03-31 |
4 |
OE |
$35.15 |
$263,625 |
D/D |
7,500 |
13,537 |
0 |
- |
|
| ORA |
Ormat Technologies Inc |
Director |
• • – |
2021-11-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,430 |
6,037 |
0 |
- |
|
| ORA |
Ormat Technologies Inc |
Director |
• • – |
2020-11-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,256 |
4,607 |
0 |
- |
|
| FOMX |
Foamix Pharmaceuticals Lt... |
Director |
– • – |
2020-03-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(42,359) |
0 |
0 |
- |
|
| FOMX |
Foamix Pharmaceuticals Lt... |
Director |
– • – |
2020-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
14,164 |
42,359 |
0 |
- |
|
| ORA |
Ormat Technologies Inc |
Director |
• • – |
2019-11-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,825 |
3,351 |
0 |
- |
|
| FOMX |
Foamix Pharmaceuticals Lt... |
Director |
– • – |
2019-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
28,195 |
28,195 |
0 |
- |
|
| ORA |
Ormat Technologies Inc |
Director |
• • – |
2018-11-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,526 |
1,526 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
